BRODSKY SMITH SHAREHOLDER UPDATE Notifying Investors ... - InvestorsObserver
DBTXDelisted Stock | USD 3.08 0.02 0.65% |
Slightly above 61% of Decibel Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Decibel Therapeutics suggests that many traders are alarmed regarding Decibel Therapeutics' prospects. Decibel Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Decibel Therapeutics' earnings reports, geopolitical events, and overall market trends.
Decibel |
BRODSKY SMITH SHAREHOLDER UPDATE Notifying Investors ... InvestorsObserver
Read at news.google.com
Decibel Therapeutics Fundamental Analysis
We analyze Decibel Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Decibel Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Decibel Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Decibel Therapeutics is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Decibel Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Decibel Therapeutics stock to make a market-neutral strategy. Peer analysis of Decibel Therapeutics could also be used in its relative valuation, which is a method of valuing Decibel Therapeutics by comparing valuation metrics with similar companies.
Peers
Decibel Therapeutics Related Equities
ANTX | AN2 Therapeutics | 21.90 | ||||
CCCC | C4 Therapeutics | 8.59 | ||||
EWTX | Edgewise Therapeutics | 2.48 | ||||
IKNA | Ikena Oncology | 2.37 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
ADAG | Adagene | 1.30 | ||||
RZLT | Rezolute | 1.00 | ||||
ACRV | Acrivon Therapeutics, | 0.80 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
MOLN | Molecular Partners | 0.17 | ||||
AVTE | Aerovate Therapeutics | 0.38 | ||||
CELC | Celcuity LLC | 0.39 | ||||
ELYM | Eliem Therapeutics | 2.25 | ||||
HCWB | HCW Biologics | 6.00 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Decibel Stock
If you are still planning to invest in Decibel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Decibel Therapeutics' history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |